ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Adaptimmune Therapeutics PLC
Financials through Q2 FY2025, quarter ended Jun 30, 2025Last filing: 10-Q on Aug 13, 2025
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026
- Market cap
- $55.46M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Adaptimmune Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2025 | Oct 20, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2025 | Sep 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 6, 2025 | Sep 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 15, 2025 | Aug 15, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2025 | Jul 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2024 | Dec 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 1, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2024 | Jul 16, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2024 | Jun 11, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | May 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2024 | Apr 12, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 14, 2024 | Apr 11, 2024 | SEC EDGAR |